skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: November 1, 2012; last reviewed: November 1, 2012)

Mycobacterium tuberculosis Infection and Disease

Member Financial Disclosure
 Company Relationship
Burman, Bill* University of Colorado Otsuka Advisory Board
Tibotec DSMB Member
El-Sadr, Wafaa Columbia University None N/A
Gandhi, Neel Rollins School of Public Health-Emory University None N/A
Havlir, Diane University of California, San Francisco None N/A
Maartens, Gary University of Cape Town, South Africa Tibotec DSMB Member
Meintjes, Graeme
University of Cape Town, South Africa Sanofi-Aventis Honoraria
Samandari, Taraz Centers for Disease Control and Prevention None N/A
* Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top